3rd Quarter - Report

AVENUE SOLUTIONS for EDWARDS LIFESCIENCES LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
MATTHEW FUENTES —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1717 (119th), H.R. 5343 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.